Boston Immune Technologies and Therapeutics (BITT) is a Boston, MA based company developing a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease. BITT is initiating clinical trials for BIR2101, its lead candidate, a monoclonal antibody that targets tumor necrosis factor receptor 2 (TNFR2). BITT is also developing additional TNF superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology.
View Top Employees from Boston Immune Technologies & Therapeutics| Website | http://www.bostonimmunetech.com |
| Revenue | $7 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2011 |
| Address | 81 Walnut St, Winchester, Massachusetts 01890, US |
| Industry | Business Services General, Therapeutics, Biotechnology, Business Services, Health Care, Pharmaceuticals |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Boston Immune Technologies & Therapeutics employee's phone or email?
Boston Immune Technologies & Therapeutics Questions
The Boston Immune Technologies & Therapeutics annual revenue was $7 million in 2024.
Lynne Soughley is the Director Clinical Operations of Boston Immune Technologies & Therapeutics.
2 people are employed at Boston Immune Technologies & Therapeutics.
Boston Immune Technologies & Therapeutics is based in Winchester, Massachusetts.
The NAICS codes for Boston Immune Technologies & Therapeutics are [54171, 541, 54, 5417, 541714].
The SIC codes for Boston Immune Technologies & Therapeutics are [873, 87].
Top Boston Immune Technologies & Therapeutics Employees
